Recommended Alerts

Sign Up For Alerts

What Awaits in the First Year of Medicare Drug Price Negotiations? CMS Issues Guidance and Solicits Comment on the 2026 Inflation Reduction Act Part D Negotiation Process

On March 15, 2023, the Centers for Medicare & Medicaid Services (“CMS”) issued an initial guidance memorandum (“Memorandum”) describing how it proposes to implement the Inflation Reduction Act Medicare Drug Price Negotiation Program (“Negotiation Program”) for the Initial Price Applicability Year of 2026 (the “Initial Year”). In the Memorandum, CMS provides further guidance regarding (i) how it intends to select the Medicare Part D drugs and biologics for which it will negotiate a maximum fair price (“MFP”) for the Initial Year (the “Selected Drugs”), (ii) the data and evidence that manufacturers will be required to submit that will inform CMS’s initial price proposals, (iii) the structure of the negotiation process, and (iv) implementation and enforcement of the MFP.

Read More

Deadline Approaching to Add Issues to Some Pending PRRB Appeals

Time to Read: 1 minutes Practices: Health Care

Printer-Friendly Version

We wanted to alert you that, for any pending PRRB appeals filed from Notices of Program Reimbursement (NPRs) or other appealable determinations received on or before February 23, 2008, the deadline for adding issues is October 20, 2008. This is due to the May 23, 2008 changes to the federal regulations governing PRRB appeals.


Note that for appeals filed from NPRs or other determinations received on or after February 24, 2008, the deadline for adding issues is 240 days after your organization receives the determination.


Some issues to consider adding include:


  • DSH Issues (e.g., Medicaid paid days; Medicare eligible but unpaid days; charity/general assistance days; dual eligible issues related to Medicare Part A exhausted days; Medicare secondary payer days; cessation of Medicare Part A benefits prior to inpatient service; Medicare Advantage days; DSH/Supplemental Security Income days)
  • Bad Debt Issues (e.g., crossover (Medicaid) claims (“must bill” policy); use of outside collection agency; 120-day presumption of uncollectibility; indigence/charity determinations; prior approval by intermediary under statutory moratorium)
  • GME/IME Issues (e.g., resident FTE counts; available beds (IME); base year issues; non-provider rotations; Medicare Advantage days)
  • Wage Index Issues (e.g., wage data corrections; wage-related costs; rural floor; budget-neutrality adjustment; disallowance of pension/post-retirement benefit costs; disallowance of contract labor costs, including consultants and attorneys)
  • Nursing/Allied Health (e.g., Medicare Advantage days)
  • Sampling/Extrapolation Issues (which could affect several of the above-mentioned areas)
  • Organ Transplant Issues (e.g., pre- and post-transplant allocations; statistics)
  • Classification/Reclassification (e.g., Medicare status; geographic classification)
  • Reporting Hospital Quality Data Issues

This is not intended to be a comprehensive list of all the issues that your organization may want to add to a pending appeal but rather a broad check-list as you review past audit adjustments. Please do not hesitate to contact us if you would like to discuss any of these issues or others that affect your organization.


Please also be aware that a new form – “Model Form C – Request To Add Issue(s) To An Individual Appeal” – must be used when adding an issue to a pending appeal. Depending on what has already been filed, it may be necessary to file a supplemental position paper with supporting materials.


If you have additional questions concerning the approaching deadline for PRRB appeals, please contact Mira BurghardtTerry Coleman, or Deborah Gardner.

Printer-Friendly Version

Cookie Settings